Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006

European Journal of Surgical Oncology

Volumn 32, Issue 5, 2006, Pages 473-483

  Hao, C Y ^a   Ji, J F ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Colorectal cancer; Liver metastases; Liver resection; Prognosis

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MONOCLONAL ANTIBODY; OXALIPLATIN;

ARTIFICIAL EMBOLISM; CANCER ADJUVANT THERAPY; CANCER PATIENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; CONSENSUS; DATA ANALYSIS; HUMAN; LAPAROSCOPIC SURGERY; LIVER METASTASIS; LIVER RESECTION; MEDLINE; PATIENT CARE; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGEON; TREATMENT CONTRAINDICATION; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; CLINICAL PROTOCOLS; COLONIC NEOPLASMS; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; LAPAROSCOPY; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PROGNOSIS; RECTAL NEOPLASMS;

EID: 33646770333     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.02.016     Document Type: Review

References (114)

1. Registry of Hepatic Metastases. Resection of the liver forcolorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 103 (1988) 278-288
2. Ambiru S., Miyazaki M., Isono T., Ito H., Nakagawa K., Shimizu H., et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 42 (1999) 632-639
3. Yamamoto J., Shimada K., Kosuge T., Yamasaki S., Sakamoto M., and Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 86 (1999) 332-337
4. Minagawa M., Makuuchi M., Torzilli G., Takayama T., Kawasaki S., Kosuge T., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231 (2000) 487-499
5. Nordlinger B., Guiguet M., Vaillant J.C., Balladur P., Boudjema K., Bachellier P., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77 (1996) 1254-1262
6. Doci R., Gennari L., Bignami P., Montalto F., Morabito A., and Bozzetti F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78 (1991) 797-801
7. Rees M., Plant G., and Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84 (1997) 1136-1140
8. Adam R., Avisar E., Ariche A., Giachetti S., Azoulay D., Castaing D., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8 (2001) 347-353
9. Bengmark S., and Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23 (1969) 198-202
10. Bengtsson G., Carlsson G., Hafstrom L., and Jonsson P.E. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141 (1981) 586-589
11. de Brauw L.M., van de Velde C.J., Bouwhuis-Hoogerwerf M.L., and Zwaveling A. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 34 (1987) 81-86
12. Biasco G., Di Battista M., and Derenzini E. Slow evolution of liver metastasis from colon cancer. Dig Liver Dis 37 (2005) 628-629
13. Scheele J., Stangl R., and Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77 (1990) 1241-1246
14. Adson M.A., van Heerden J.A., Adson M.H., Wagner J.S., and Ilstrup D.M. Resection of hepatic metastases from colorectal cancer. Arch Surg 119 (1984) 647-651
15. Wilson S.M., and Adson M.A. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111 (1976) 330-334
16. Lise M., Bacchetti S., Da Pian P., Nitti D., and Pilati P. Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg 25 (2001) 638-644
17. Ueno H., Mochizuki H., Hatsuse K., Hase K., and Yamamoto T. Indicators for treatment strategies of colorectal liver metastases. Ann Surg 231 (2000) 59-66
18. Schemed M., Wigmore S.J., Currie E.J., Laengle F., and Garden O.J. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg 140 (2005) 183-189
19. Iwatsuki S., Dvorchik I., Madariaga J.R., Marsh J.W., Dodson F., Bonham A.C., et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189 (1999) 291-299
20. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
21. Jaeck D., Nakano H., Bachellier P., Inoue K., Weber J.C., Oussoultzoglou E., et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 9 (2002) 430-438
22. Wanebo H.J., Chu Q.D., Vezeridis M.P., and Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg 131 (1996) 322-329
23. Weber S.M., Jarnagin W.R., DeMatteo R.P., Blumgart L.H., and Fong Y. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 7 (2000) 643-650
24. Adam R., Pascal G., Castaing D., Azoulay D., Delvart V., Paule B., et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052-1061
25. Nordlinger B., Jaeck D., Guiguet M., Vaillant J.C., Balladur P., and Schaal J.C. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B., and Jaeck D. (Eds). Treatment of hepatic metastases of colorectal cancer (1992), Springer, Paris 129-146
26. Ekberg H., Tranberg K.G., Andersson R., Lundstedt C., Hagerstrand I., Ranstam J., et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73 (1986) 727-731
27. Cady B., Jenkins R.L., Steele Jr. G.D., Lewis W.D., Stone M.D., McDermott W.V., et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227 (1998) 566-571
28. Shirabe K., Takenaka K., Gion T., Fujiwara Y., Shimada M., Yanaga K., et al. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 84 (1997) 1077-1080
29. Elias D., Liberale G., Vernerey D., Pocard M., Ducreux M., Boige V., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12 (2005) 900-909
30. Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 10 (2003) 1007-1011
31. Pawlik T.M., Scoggins C.R., Zorzi D., Abdalla E.K., Andres A., Eng C., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 (2005) 715-722
32. Fornari F., Civardi G., Cavanna L., Di Stasi M., Rossi S., Sbolli G., et al. Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. Scand J Gastroenterol 24 (1989) 949-955
33. Smith E.H. Complications of percutaneous abdominal fine-needle biopsy. Radiology 178 (1991) 253-258
34. Jones O.M., Rees M., John T.G., Bygrave S., and Plant G. Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg 92 (2005) 1165-1168
35. Rodgers M.S., Collinson R., Desai S., Stubbs R.S., and McCall J.L. Risk of dissemination with biopsy of colorectal liver metastases. Dis Colon Rectum 46 (2003) 454-459
36. Ohlsson B., Nilsson J., Stenram U., Akerman M., and Tranberg K.G. Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours. Br J Surg 89 (2002) 757-762
37. Findlay M., Young H., Cunningham D., Iveson A., Cronin B., Hickish T., et al. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14 (1996) 700-708
38. Beets G., Penninckx F., Schiepers C., Filez L., Mortelmans L., Kerremans R., et al. Clinical value of whole-body positron emission tomography with [18F] fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 81 (1994) 1666-1670
39. Fong Y., Saldinger P.F., Akhurst T., Macapinlac H., Yeung H., Finn R.D., et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178 (1999) 282-287
40. Potter M.W., Shah S.A., McEnaney P., Chari R.S., and Callery M.P. A critical appraisal of laparoscopic staging in hepatobiliary and pancreatic malignancy. Surg Oncol 9 (2000) 103-110
41. Selzner M., Hany T.F., Wildbrett P., McCormack L., Kadry Z., and Clavien P.A. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg 240 (2004) 1027-1034
42. Thaler K., Kanneganti S., Khajanchee Y., Wilson C., Swanstrom L., and Hansen P.D. The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Arch Surg 140 (2005) 727-734
43. Murata S., Moriya Y., Akasu T., Fujita S., and Sugihara K. Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 83 (1998) 1086-1093
44. Rahusen F.D., Cuesta M.A., Borgstein P.J., Bleichrodt R.P., Barkhof F., Doesburg T., et al. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg 230 (1999) 31-37
45. Couinaud C. Le foie. Etudes anatomiques et chirurgicales (1957), Masson, Paris p. 284-289
46. Healey Jr. J.E., and Schroy P.C. Anatomy of the biliary ducts within the human liver; analysis of the prevailing pattern of branchings and the major variations of the biliary ducts. AMA Arch Surg 66 (1953) 599-616
47. Healey Jr. J.E. Clinical anatomic aspects of radical hepatic surgery. J Int Coll Surg 22 (1954) 542-550
48. Strasberg S.M. Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg 184 (1997) 413-434
49. Strasberg S., Belghiti J., Clavien P.A., Gadzijev E., Garden J.O., Lau W.-Y., et al. The Brisbane 2000 terminology of liver anatomy and resections. HPB 3 (2000) 333-339
50. Staren E.D., Gambla M., Deziel D.J., Velasco J., Saclarides T.J., Millikan K., et al. Intraoperative ultrasound in the management of liver neoplasms. Am Surg 63 (1997) 591-596
51. Stadler J., Holscher A.H., and Adolf J. Intraoperative ultrasonographic detection of occult liver metastases in colorectal cancer. Surg Endosc 5 (1991) 36-40
52. Ozsunar Y., Skjoldbye B., Court-Payen M., Karstrup S., and Burcharth F. Impact of intraoperative ultrasonography on surgical treatment of liver tumours. Acta Radiol 41 (2000) 97-101
53. Cady B., Monson D.O., and Swinton N.W. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131 (1970) 697-700
54. Michelassi F., Block G.E., Vannucci L., Montag A., and Chappell R. A 5-to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 208 (1988) 379-389
55. Pescatori M., Mattana C., Maria G., Ferrara A., and Lucibello L. Outcome of colorectal cancer. Br J Surg 74 (1987) 370-372
56. Bolton J., and Fuhrman G.M. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 231 (2000) 743-751
57. Cady B., and Stone M.D. The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 18 (1991) 399-406
58. Scheele J. Hepatectomy for liver metastases. Br J Surg 80 (1993) 274-276
59. Lambert L.A., Colacchio T.A., and Barth Jr. R.J. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 135 (2000) 473-480
60. Bismuth H., Castaing D., and Traynor O. Surgery for synchronous hepatic metastases of colorectal cancer. Scand J Gastroenterol 149 Suppl (1988) 144-149
61. Scheele J., Stang R., Altendorf-Hoffman A., and Paul M. Resection of colorectal metastases. World J Surg 19 (1995) 59-71
62. Belghiti J. Synchronous and resectable hepatic metastases of colorectal cancer: should there be a minimum delay before hepatic resection?. Ann Chir 44 (1990) 427-429
63. Tanaka K., Shimada H., Matsuo K., Nagano Y., Endo I., Sekido H., et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 136 (2004) 650-659
64. Martin R., Paty P., Fong Y., Grace A., Cohen A., DeMatteo R., et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197 (2003) 233-241
65. Weber J.C., Bachellier P., Oussoultzoglou E., and Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 90 (2003) 956-962
66. Hughes K.S., Simon R., Songhorabodi S., Adson M.A., Ilstrup D.M., Fortner J.G., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100 (1986) 278-284
67. Adam R., Pascal G., Azoulay D., Tanaka K., Castaing D., and Bismuth H. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238 (2003) 871-883
68. Adam R., Bismuth H., Castaing D., Waechter F., Navarro F., Abascal A., et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 225 (1997) 51-60
69. Yamamoto J., Kosuge T., Shimada K., Yamasaki S., Moriya Y., and Sugihara K. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 178 (1999) 275-281
70. Zacharias T., Jaeck D., Oussoultzoglou E., Bachellier P., and Weber J.C. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg 240 (2004) 858-865
71. Elias D., Cavalcanti A., Sabourin J.C., Pignon J.P., Ducreux M., and Lasser P. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 69 (1998) 88-93
72. Adam R., Delvart V., Pascal G., Valeanu A., Castaing D., Azoulay D., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
73. Heidelberger C., Chaudhuri N.K., Danneberg P., Mooren D., Griesbach L., Duschinsky R., et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179 (1957) 663-666
74. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
75. Grothey A., Deschleer B., and Kroening H. Bolus 5-fluorouracil (5-FU)/folinic acid (FA) (Mayo) vs weekly high-dose 24 H 5-FU infusion/FA+ oxaliplatin (OXA) in advanced colorectal cancer (CRC): results of a phase III study. Proc Am Soc Clin Oncol 20 (2001) 125a [Abstract 496]
76. Tournigand C., Andre T., Achille E., Lledo G., Flesh M., Mery-Mignard D., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22 (2004) 229-237
77. Giacchettti S., Bjarnason G., and Garufi C. First line infusion of 5-fluorouracil, leucovorin and oxaliplatin for metastatic colorecral cancer: 4-day chronomodulated (FFL4-10) versus 2-day FOLFOX2-a multicenter rqndomiwed phase III trial of the Chronotherpy Group of the European Organization for Research and Treatment of Cancer (EORTC 05963). Proc Am Soc Clin Oncol 2 (2004) 252 [Abstract 3526]
78. Grothey A., Jordan K., and Kellner O. Capacitabine/irinotecan (Capiri) and capecitabine/oxaliplatin (CapOx) are active second-line protocols in patients with advanced colorectal cancer (ACRC) after failure of first-line combination therapy: results of a randomised phase II study. Proc Am Soc Clin Oncol 23 (2004) 254 [Abstract 3534]
79. Aparicio A., Iqbai S., and Yang D. Pilot trial of 5-FU/oxaliplatin (CIFOX) for patients with metastatic colorectal cancer who progressed on 5-FU/LV/CPT-11 (IFL). Proc Am Soc Clin Oncol 23 (2004) 313 [Abstract 3773]
80. Pfeiffer P., Glimelius B., and Sorbye S. Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) in patients with progressive colorectal cancer after irinotecan and 5-fuorouraccil (FU) treatment. Proc Am Soc Clin Oncol 23 (2004) 261 [Abstract 3562]
81. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88 (1996) 252-258
82. Kemeny N.E., Niedzwiecki D., and Hollis D.R. Final analysis: hepatic arterial infusion (HAI) versus systemic therapy for hepatic metastases from colorectal cancer-a CALGB randomized trial of efficacy, quality of life (QOL), cost effectiveness, and molecular markers. ASCI Gastrointest Cancer Symp 176 (2005) 183 [Abstract 183]
83. Kemeny N., Gonen M., Sullivan D., Schwartz L., Benedetti F., Saltz L., et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 19 (2001) 2687-2695
84. Doria Jr. M.I., Shepard K.V., Levin B., and Riddell R.H. Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR. Cancer 58 (1986) 855-861
85. Kemeny N., Niedzwiecki D., Shurgot B., and Oderman P. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer 63 (1989) 742-747
86. Kemeny M.M., Adak S., Gray B., Macdonald J.S., Smith T., Lipsitz S., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 20 (2002) 1499-1505
87. Ducreux M., Ychou M., Laplanche A., Gamelin E., Lasser P., Husseini F., et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23 (2005) 4881-4887
88. Kemeny N., Jarnagin W., Paty P., Gonen M., Schwartz L., Morse M., et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23 (2005) 4888-4896
89. Shimonov M., Hayat H., Chaitchik S., Brener J., Schachter P., and Czerniak A. Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver. Chemotherapy 51 (2005) 111-115
90. Cunningham D., Humblet Y., Siena S., Khayat D., Bleiberg H., Santoro A., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
91. Chung K.Y., Shia J., Kemeny N.E., Shah M., Schwartz G.K., Tse A., et al. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol 23 (2005) 1803-1810
92. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
93. Kabbinavar F.F., Hambleton J., Mass R.D., Hurwitz H.I., Bergsland E., and Sarkar S. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23 (2005) 3706-3712
94. Adam R., Lucidi V., and Bismuth H. Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am 84 (2004) 659-671
95. Kokudo N., and Makuuchi M. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 84 (2004) 643-657
96. de Baere T., Roche A., Elias D., Lasser P., Lagrange C., and Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24 (1996) 1386-1391
97. Vauthey J.N., Chaoui A., Do K.A., Bilimoria M.M., Fenstermacher M.J., Charnsangavej C., et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127 (2000) 512-519
98. Jaeck D., Bachellier P., Nakano H., Oussoultzoglou E., Weber J.C., Wolf P., et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185 (2003) 221-229
99. Azoulay D., Castaing D., Smail A., Adam R., Cailliez V., Laurent A., et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231 (2000) 480-486
100. Oussoultzoglou E, Bachellier P, Rosso E, Scurtu R, Lucescu I, Greget M, et al. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intra-hepatic recurrence rate. Ann surg; in press.
101. Abdalla E.K., Hicks M.E., and Vauthey J.N. Portal vein embolization: rationale, technique and future prospects. Br J Surg 88 (2001) 165-175
102. Di Stefano D.R., de Baere T., Denys A., Hakime A., Gorin G., Gillet M., et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234 (2005) 625-630
103. Elias D., De Baere T., Roche A., Mducreux, Leclere J., and Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86 (1999) 784-788
104. Jaeck D., Oussoultzoglou E., Rosso E., Greget M., Weber J.C., and Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240 (2004) 1037-1049
105. Navarra G., Ayav A., Weber J.C., Jensen S.L., Smadga C., Nicholls J.P., et al. Short- and -long term results of intraoperative radiofrequency ablation of liver metastases. Int J Colorectal Dis 20 (2005) 521-528
106. Curley S.A., Izzo F., Delrio P., Ellis L.M., Granchi J., Vallone P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230 (1999) 1-8
107. Weaver M.L., Ashton J.G., and Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 14 (1998) 163-170
108. Brooks A.J., Wang F., Alfredson M., Yan T.D., and Morris D.L. Synchronous liver resection and cryotherapy for colorectal metastases: survival analysis. Surgeon 3 (2005) 265-268
109. Kennedy J.E., Wu F., ter Haar G.R., Gleeson F.V., Phillips R.R., Middleton M.R., et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics 42 (2004) 931-935
110. Li C.X., Xu G.L., Jiang Z.Y., Li J.J., Luo G.Y., Shan H.B., et al. Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J Gastroenterol 10 (2004) 2201-2204
111. Azagra J.S., Goergen M., Gilbart E., and Jacobs D. Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc 10 (1996) 758-761
112. Gigot J.F., Glineur D., Santiago Azagra J., Goergen M., Ceuterick M., Morino M., et al. Hepatobiliary and Pancreatic Section of the Royal Belgian Society of Surgery and the Belgian Group for Endoscopic Surgery. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 236 (2002) 90-97
113. Cherqui D., Husson E., Hammoud R., Malassagne B., Stephan F., Bensaid S., et al. Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg 232 (2000) 753-762
114. Vibert E., Perniceni T., Levard H., Denet C., Shahri N.K., and Gayet B. Laparoscopic liver resection. Br J Surg 93 (2006) 67-72